Q4 2026 PI Industries Ltd Earnings Call Transcript
Key Points
- PI Industries Ltd (BOM:523642) reported a consolidated revenue of $67,137 million with healthy EBITDA margins of 25%, showcasing resilience in a challenging market.
- The company's pharma business delivered a 40% growth for the full year, indicating strong customer engagement and investment in capabilities.
- PI Industries Ltd (BOM:523642) has maintained its position in the S&P Global Yearbook, with an improved percentile of 98, highlighting its commitment to sustainability.
- The company has commercialized five new molecules in EQM exports and launched four new products in domestic agri brands, contributing to a focused de-risking strategy.
- PI Industries Ltd (BOM:523642) has successfully implemented SAP S/4HANA, marking a key milestone in its digital transformation journey, enhancing operational efficiency and governance.
- The global crop protection market continues to face a multi-year down cycle, with recovery remaining uneven due to global events and conflicts.
- Domestic agrochemical demand has been impacted by channel inventory, pricing pressure, and lower crop acreages, affecting key crops.
- The company's asset turns have decreased from 2.5x to 1.5x, with a significant CapEx not yet translating into expected revenue growth.
- There is a noted decline in EQM exports due to lower volumes, reflecting broader global industry contraction and customer delivery schedules.
- The company faces challenges in the pharma sector due to external environment investments and reduced biotech startup activities, impacting growth momentum.
Ladies and Gentlemen, Good day and welcome to PI Industries Limited Earnings Conference Call.
As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes.
Should you need assistance during this conference call, please signal an operator by pressing *0 on your touch tone phone.
Please note that this conference is being recorded.
And now in the conference. Over to Mr. Nishat Falanki from CDR India.
Thank you, and over to you, sir.
Thank you. Good afternoon, everyone, and thank you for joining us on PI Industries Q4 FY26 Earnings Conference Call. Today, we are joined by senior members of the management team, including Mr. Mayank Singhal, Executive Vice Chairman and Managing Director, Mr. Sanjay Agarwal, Group Chief Financial Officer, Dr. Atul Gupta, CEO, CSM Atkin. Mr. Jagresh Rama, Global CEO of PI Ag Sciences, and Dr. Ramesh Sugamanian, Global CEO of PI Health Sciences. We shall
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
